Written Question·Department of Health and Social Care·UIN 82357

Omaveloxolone

Tabled: 15 October 2025

Answered: 22 October 2025

Question

Sarah Olney

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the National Institute for Health and Care Excellence on approval of Skyclarys; and if he will consider the urgent provision of Skyclarys for patients on an

Answer

Dr Zubir Ahmed

The National Institute for Health and Care Excellence (NICE) initiated the appraisal of Skyclarys (omaveloxolone) for the treatment of Friedrich’s Ataxia for people aged 16 years old and over in anticipation of a licence bring granted by the Medicines and...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 82357) →